US Broker Ratings

Bicara Therapeutics Inc. (BCAX): Investor Outlook Reveals an 89.84% Potential Upside in Biotech Market

In the competitive realm of biotechnology, Bicara Therapeutics Inc. (NASDAQ: BCAX) presents a compelling opportunity for investors seeking high-growth potential in the healthcare sector. With a market capitalization of approximately..

Arbutus Biopharma (ABUS) Stock Analysis: Exploring a 35% Upside Potential Amidst Biotech Challenges

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its promising pipeline aimed at tackling chronic infectious diseases, particularly Hepatitis B...

Immatics N.V. (IMTX): Investor Outlook Reveals an 85% Upside Potential Amidst Groundbreaking Cancer Therapies

For individual investors exploring opportunities in the biotechnology sector, Immatics N.V. (NASDAQ: IMTX) presents a compelling case with its innovative approach to cancer treatment and a significant potential upside of..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Pioneer with an 80.92% Potential Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is capturing the attention of investors with its cutting-edge biotechnological advancements and staggering potential upside. Specializing in therapies for central nervous system (CNS) disorders,..

GH Research PLC (GHRS) Stock Analysis: Exploring a Promising 113.5% Upside in the Biotech Arena

GH Research PLC (NASDAQ: GHRS), a Dublin-based clinical-stage biopharmaceutical company, is making significant waves in the biotechnology sector. With a market capitalization of $980.06 million, GH Research is dedicated to..

Pharvaris N.V. (PHVS) Stock Analysis: A 65% Upside Potential in the Biotech Sector

Pharvaris N.V. (PHVS) is capturing investor attention with its promising position in the biotechnology industry. Headquartered in Zug, Switzerland, this late-stage biopharmaceutical company is dedicated to developing therapies for rare..

Geron Corporation (GERN) Stock Analysis: An Insight into the Biotech Player’s 77% Potential Upside

Geron Corporation (NASDAQ: GERN) stands as a compelling player in the biotechnology sector, focusing on innovative therapeutic solutions for oncology. With its flagship product, RYTELO, positioned as a telomerase inhibitor..

Cronos Group Inc. (CRON) Stock Analysis: Weighing Potential Upside Amid Revenue Growth

As the cannabis industry continues to evolve in Canada and beyond, Cronos Group Inc. (NASDAQ: CRON) stands out as an intriguing player in the sector. With a market capitalization of..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Capitalizing on a Promising 113.78% Upside

Gyre Therapeutics, Inc. (NASDAQ: GYRE) has captured the attention of investors with its impressive potential upside of 113.78%, positioning itself as a compelling opportunity in the biotechnology sector. This healthcare..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Gem with 58% Upside and Strong Buy Ratings

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment. Headquartered in Boulder, Colorado, this clinical-stage biopharmaceutical company..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 219.84% Potential Upside Awaits Investors

Niagen Bioscience, Inc. (NAGE), a key player in the biotechnology sector, has been capturing investor attention due to its impressive growth potential. As a company focused on the development of..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Evaluating Growth Prospects Amidst a Moderate Analyst Consensus

Phibro Animal Health Corporation (NASDAQ: PAHC) stands out in the healthcare sector as a key player in the niche market of animal health and mineral nutrition. As a well-established entity..

InMode Ltd. (INMD) Stock Analysis: A 11.3% Potential Upside with Strong Revenue Growth

InMode Ltd. (NASDAQ: INMD), a burgeoning player in the healthcare sector, is carving out a significant niche in the medical devices industry. Specializing in cutting-edge, minimally invasive aesthetic medical products,..

Syndax Pharmaceuticals (SNDX) Stock Analysis: An 88% Potential Upside Ignites Investor Interest

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a prominent player in the biotechnology sector, is captivating investor attention with its impressive potential upside of 88.64%. Headquartered in New York, this commercial-stage biopharmaceutical..

SAP SE (SAP) Stock Analysis: Potential 46.64% Upside with Strong Analyst Ratings

SAP SE (NYSE: SAP), a stalwart in the technology sector and a leader in the application software industry, continues to captivate investors with its expansive portfolio of enterprise solutions and..

Paylocity Holding Corporation (PCTY) Stock Analysis: Unveiling a 55.81% Potential Upside

Paylocity Holding Corporation (NASDAQ: PCTY), a prominent player in the technology sector, particularly within the Software – Application industry, presents a compelling opportunity for investors seeking growth potential. With its..

Ribbon Communications Inc. (RBBN) Stock Analysis: A Look at the 80% Potential Upside for Investors

Ribbon Communications Inc. (NASDAQ: RBBN), a key player in the technology sector, stands out with its application software solutions catering to a global market. With a current market capitalization of..

Diebold Nixdorf (DBD): Analyst Ratings Signal a Promising 19.80% Upside

Diebold Nixdorf, Incorporated (NYSE: DBD) is making waves in the technology sector, specifically within the software application industry, with its innovative solutions designed to automate, digitize, and transform banking and..

RingCentral, Inc. (RNG) Stock Analysis: Is the 11.86% Potential Upside Worth the Investment?

RingCentral, Inc. (NYSE: RNG), a notable player in the technology sector, operates in the Software – Application industry. Headquartered in Belmont, California, the company is renowned for its innovative cloud..

Similarweb Ltd. (SMWB) Stock Analysis: Is a 238.94% Upside Within Reach?

For investors seeking transformative opportunities in the technology sector, Similarweb Ltd. (NASDAQ: SMWB) offers a compelling case. Despite its current challenges, the potential upside of 238.94% as per analyst ratings..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds